These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 10094567)

  • 1. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.
    Oetting WS; King RA
    Hum Mutat; 1999; 13(2):99-115. PubMed ID: 10094567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene.
    Oetting WS
    Hum Mutat; 2002 Feb; 19(2):85-92. PubMed ID: 11793467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albinism in Europe.
    Mártinez-García M; Montoliu L
    J Dermatol; 2013 May; 40(5):319-24. PubMed ID: 23668539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
    Ullah MI
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
    Oetting WS; Fryer JP; King RA
    Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oculocutaneous albinism.
    Grønskov K; Ek J; Brondum-Nielsen K
    Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oculocutaneous albinism].
    Lacour JP; Ortonne JP
    Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
    Ray K; Chaki M; Sengupta M
    Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinal pigmentation pathway in human albinism: Not so black and white.
    Bakker R; Wagstaff EL; Kruijt CC; Emri E; van Karnebeek CDM; Hoffmann MB; Brooks BP; Boon CJF; Montoliu L; van Genderen MM; Bergen AA
    Prog Retin Eye Res; 2022 Nov; 91():101091. PubMed ID: 35729001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online.
    Oetting WS; Gardner JM; Fryer JP; Ching A; Durham-Pierre D; King RA; Brilliant MH
    Hum Mutat; 1998; 12(6):434. PubMed ID: 10671067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromic albinism: a review of genetics and phenotypes.
    Scheinfeld NS
    Dermatol Online J; 2003 Dec; 9(5):5. PubMed ID: 14996378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
    Preising MN; Forster H; Gonser M; Lorenz B
    Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.